Adebrelimab Combine With Etoposide Capsules in ES-SCLC Maintenance Therapy

Clinical trial NCT07141264 · RECRUITING

Trial details

NCT number: NCT07141264
Sponsor: Tang-Du Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

SCLC,Extensive Stage

Start date: 2025-08-25
Primary completion: 2026-12-30
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.